Mycophenolate mofetil and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Revlimid (lenalidomide). Common drug interactions include dizziness among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Revlimid. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

79 people who take Mycophenolate mofetil and Revlimid together, and have interactions are studied.

Mycophenolate mofetil and Revlimid drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Revlimid, by gender? *:

female:

Dizziness
Pulmonary embolism (blockage of the main artery of the lung)
Blood pressure decreased
Chest pain
Diarrhoea
Epistaxis (bleed from the nose)
Herpes zoster
Injury
Laceration (tearing of soft body tissue)
Haemoglobin decreased

male:

Hypotension (abnormally low blood pressure)
Diarrhoea
Weight decreased
Anal fistula
Fall
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Sepsis (a severe blood infection that can lead to organ failure and death)
White blood cell count decreased
Circulatory collapse
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Mycophenolate Mofetil and Revlimid, by age (0-1 to 60+)? *:

0-1:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Tracheal stenosis (narrowing of trachea)

2-9:

n/a

10-19:

Fluid retention (an abnormal accumulation of fluid in the blood)
Haemoglobin decreased
Pulmonary embolism (blockage of the main artery of the lung)

20-29:

Actinic keratosis (skin disease due to sun exposure)
Acute respiratory failure
Altered state of consciousness (altered state of mind)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Atelectasis (partial or complete collapse of the lung)
Back pain
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Bladder diverticulum (pouch like projection in the bladder, by birth or acquired)

30-39:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)

40-49:

Sepsis (a severe blood infection that can lead to organ failure and death)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Death
Injection site erythema (redness at injection site)
Injection site induration
Injection site infection
Injection site pain
Injection site swelling

50-59:

Tumour flare (temporary increase in symptoms from a cancer after starting treatment)
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Haemolytic anaemia (anaemia due to haemolysis)
Lacrimal disorder (disease of lacrimal duct)
Lymphadenopathy (disease or enlargement of lymph nodes)
Mass
Nodule (a growth of abnormal tissue)
Parophthalmia (inflammation of the connective tissue around the eye)
Pulmonary mass
Death

60+:

Neutropenia (an abnormally low number of neutrophils)
Fall
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Anal fistula
Dizziness
Hypotension (abnormally low blood pressure)
Nausea (feeling of having an urge to vomit)
Renal failure (kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 7.59%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 6.33%
Immunodeficiency Disorders: 5 people, 6.33%
Pain: 4 people, 5.06%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 5.06%
Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 5.06%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously